Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
01.06.21 | AAC Clyde Space - Progress as consolidation phase commences | 483 | Edison Investment Research | AAC Clyde Space has delivered a strong Q121 with revenue growth of 55% and a substantial reduction in EBITDA losses. The ongoing activities continued to develop, positively augmented by initial contributions... ► Artikel lesen | |
01.06.21 | Fidelity China Special Situations - Seeking out and capitalising on structural winners | 259 | Edison Investment Research | Fidelity China Special Situations (FCSS) aims to deliver long-term capital growth from a portfolio of stocks listed mainly in China and Chinese companies listed abroad. Manager Dale Nicholls focuses... ► Artikel lesen | |
01.06.21 | Borussia Dortmund - Nice finish | 598 | Edison Investment Research | Borussia Dortmund's Q321 results reflected ongoing cost control, while COVID continued to affect attendance-related revenues. The team's late surge to finish third in the Bundesliga, and more silverware... ► Artikel lesen | |
01.06.21 | Nynomic - Growth in a time of coronavirus | 445 | Edison Investment Research | Demand for Nynomic's smart, miniaturised measurement technology is benefitting from the new automated production methodologies often referred to as industry 4.0. Revenue growth in FY20 and FY21 is supported... ► Artikel lesen | |
01.06.21 | Ergomed - What's next after stellar 2020 performance? | 294 | Edison Investment Research | Although most of 2020 was challenging for the contract research outsourcing (CRO) sector, for Ergomed it was a transformative growth period due to well-balanced pharmacovigilance (PV) and CRO offerings.... ► Artikel lesen | |
01.06.21 | AlzeCure Pharma - Catalysts on the horizon | 306 | Edison Investment Research | AlzeCure remains on track with its evolution into a mid-stage biotech, having recently reported positive headline data from its Phase Ib trial for ACD440, topical TRPV1 antagonist for pain. The company... ► Artikel lesen | |
01.06.21 | Medlab Clinical - Novel drug delivery and synthetic cannabinoids | 234 | Edison Investment Research | Medlab is a drug delivery biotechnology company with a proprietary platform, NanoCelle, which is a patented nanomicellar formulation that can improve the delivery of drugs. With the growing appreciation... ► Artikel lesen | |
01.06.21 | Datagroup - Back on track | 718 | Edison Investment Research | After a difficult FY20, IT services provider DATAGROUP's earnings recovered in H121, driven by a turnaround in its Financial IT Services (FIS) unit, which took a hit in FY20. The M&A-driven business... ► Artikel lesen | |
01.06.21 | Thin Film Electronics - Happy first anniversary of microbattery strategy | 289 | Edison Investment Research | Q121 marks the first anniversary of Thin Film Electronics' (Thinfilm) strategic pivot to commercialising its proprietary ultra-thin solid-state microbattery product for applications such as hearing... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 579 |
BAYER | 371 |
BYD | 318 |
NEL | 303 |
NVIDIA | 279 |
TUI | 264 |
PLUG POWER | 257 |
TESLA | 256 |
DEUTSCHE BANK | 254 |
SUPER MICRO COMPUTER | 240 |
APPLE | 227 |
RHEINMETALL | 220 |
RWE | 208 |
DEUTSCHE LUFTHANSA | 196 |
MERCEDES-BENZ | 192 |
AMAZON | 190 |
BERKSHIRE HATHAWAY | 179 |
RENK GROUP | 154 |
VOLKSWAGEN | 149 |
ALLIANZ | 147 |
COMMERZBANK | 147 |
BIONTECH | 145 |
AIXTRON SE | 144 |
PAYPAL | 140 |
BASF | 139 |